Preface |
|
xii | |
Section I Fundamentals Of Microbiology |
|
1 | (126) |
|
|
|
1 The Science of Microbiology |
|
|
1 | (10) |
|
|
1 | (1) |
|
Biologic Principles Illustrated by Microbiology |
|
|
1 | (1) |
|
|
2 | (1) |
|
|
3 | (1) |
|
|
4 | (3) |
|
|
7 | (2) |
|
|
9 | (1) |
|
|
9 | (2) |
|
|
11 | (32) |
|
|
11 | (2) |
|
Eukaryotic Cell Structure |
|
|
13 | (2) |
|
Prokaryotic Cell Structure |
|
|
15 | (23) |
|
|
38 | (1) |
|
Morphologic Changes During Growth |
|
|
39 | (1) |
|
|
40 | (1) |
|
|
40 | (3) |
|
3 Classification of Bacteria |
|
|
43 | (12) |
|
TaxonomyThe Vocabulary of Medical Microbiology |
|
|
43 | (1) |
|
Criteria for Identification of Bacteria |
|
|
43 | (3) |
|
|
46 | (2) |
|
Description of the Major Categories and Groups of Bacteria |
|
|
48 | (4) |
|
Nonculture Methods for the Identification of Pathogenic Microorganisms |
|
|
52 | (1) |
|
|
53 | (1) |
|
|
53 | (2) |
|
4 Growth, Survival, and Death of Microorganisms |
|
|
55 | (14) |
|
Survival of Microorganisms in the Natural Environment |
|
|
55 | (1) |
|
|
55 | (1) |
|
|
56 | (1) |
|
The Growth Curve in Batch Culture |
|
|
57 | (1) |
|
Maintenance of Cells in the Exponential Phase |
|
|
58 | (1) |
|
|
58 | (1) |
|
Definition and Measurement of Death |
|
|
59 | (1) |
|
Environmental Control of Microbial Growth |
|
|
59 | (1) |
|
Strategies to Control Bacteria at the Environmental Level |
|
|
59 | (1) |
|
General Mechanisms of Biocide Action |
|
|
60 | (3) |
|
Specific Actions of Selected Biocides |
|
|
63 | (1) |
|
Relationship of Biocide Concentration and Time on Antimicrobial Killing |
|
|
64 | (1) |
|
|
65 | (1) |
|
|
65 | (1) |
|
|
66 | (3) |
|
5 Cultivation of Microorganisms |
|
|
69 | (12) |
|
|
69 | (1) |
|
Sources of Metabolic Energy |
|
|
69 | (1) |
|
|
70 | (1) |
|
Environmental Factors Affecting Growth |
|
|
71 | (3) |
|
|
74 | (4) |
|
|
78 | (1) |
|
|
78 | (3) |
|
|
81 | (24) |
|
Role of Metabolism in Biosynthesis and Growth |
|
|
81 | (1) |
|
Focal Metabolites and Their Interconversion |
|
|
81 | (3) |
|
|
84 | (8) |
|
|
92 | (2) |
|
Patterns of Microbial Energy-Yielding Metabolism |
|
|
94 | (7) |
|
Regulation of Metabolic Pathways |
|
|
101 | (2) |
|
|
103 | (1) |
|
|
103 | (2) |
|
|
105 | (22) |
|
Nucleic Acids and Their Organization in Eukaryotic, Prokaryotic, and Viral Genomes |
|
|
105 | (5) |
|
|
110 | (1) |
|
|
111 | (3) |
|
Mutation and Gene Rearrangement |
|
|
114 | (1) |
|
|
115 | (2) |
|
|
117 | (3) |
|
Characterization of Cloned DNA |
|
|
120 | (3) |
|
Site-Directed Mutagenesis |
|
|
123 | (1) |
|
Analysis With Cloned DNA: Hybridization Probes |
|
|
124 | (1) |
|
Manipulation of Cloned DNA |
|
|
124 | (1) |
|
|
125 | (1) |
|
|
125 | (2) |
Section II Immunology |
|
127 | (26) |
|
|
|
127 | (26) |
|
|
127 | (1) |
|
|
127 | (3) |
|
|
130 | (11) |
|
|
141 | (2) |
|
|
143 | (2) |
|
|
145 | (1) |
|
Deficiencies of the Immune Response |
|
|
146 | (1) |
|
Clinical Immunology Laboratory (Diagnostic Testing) |
|
|
147 | (2) |
|
|
149 | (1) |
|
|
149 | (4) |
Section III Bacteriology |
|
153 | (244) |
|
|
|
9 Pathogenesis of Bacterial Infection |
|
|
153 | (16) |
|
Identifying Bacteria That Cause Disease |
|
|
154 | (1) |
|
Transmission of Infection |
|
|
155 | (1) |
|
|
156 | (1) |
|
Genomics and Bacterial Pathogenicity |
|
|
156 | (1) |
|
Regulation of Bacterial Virulence Factors |
|
|
157 | (1) |
|
Bacterial Virulence Factors |
|
|
158 | (7) |
|
|
165 | (1) |
|
|
165 | (4) |
|
10 Normal Human Microbiota |
|
|
169 | (10) |
|
|
169 | (1) |
|
Role of the Resident Microbiota |
|
|
169 | (2) |
|
Normal Microbiota of the Skin |
|
|
171 | (1) |
|
Normal Microbiota of the Mouth and Upper Respiratory Tract |
|
|
171 | (5) |
|
Normal Microbiota of the Urethra |
|
|
176 | (1) |
|
Normal Microbiota of the Vagina |
|
|
176 | (1) |
|
Normal Microbiota of the Conjunctiva |
|
|
176 | (1) |
|
|
177 | (1) |
|
|
177 | (2) |
|
11 Spore-Forming Gram-Positive Bacilli: Bacillus and Clostridium Species |
|
|
179 | (12) |
|
|
179 | (1) |
|
|
179 | (3) |
|
|
182 | (1) |
|
|
182 | (1) |
|
|
183 | (1) |
|
|
184 | (2) |
|
Clostridia That Produce Invasive Infections |
|
|
186 | (1) |
|
Clostridium difficile and Diarrheal Disease |
|
|
187 | (1) |
|
|
188 | (3) |
|
12 Aerobic Non-Spore-Forming Gram-Positive Bacilli: Corynebacterium, Listeria, Erysipelothrix, Nocardia, and Related Pathogens |
|
|
191 | (12) |
|
Corynebacterium diphtheriae |
|
|
192 | (3) |
|
Other Coryneform Bacteria |
|
|
195 | (1) |
|
|
196 | (2) |
|
Erysipelothrix rhusiopathiae |
|
|
198 | (1) |
|
Complex Aerobic Actinomycetes |
|
|
198 | (1) |
|
|
199 | (1) |
|
|
200 | (1) |
|
|
200 | (3) |
|
|
203 | (10) |
|
|
210 | (1) |
|
|
210 | (3) |
|
14 The Streptococci, Enterococci, and Related Genera |
|
|
213 | (18) |
|
Classification of Streptococci |
|
|
213 | (2) |
|
Streptococci of Particular Medical Interest |
|
|
215 | (1) |
|
|
215 | (5) |
|
|
220 | (1) |
|
|
220 | (1) |
|
|
221 | (1) |
|
Streptococcus anginosus Group |
|
|
221 | (1) |
|
Groups E, F, G, H, and K-U Streptococci |
|
|
221 | (1) |
|
|
221 | (1) |
|
Nutritionally Variant Streptococci |
|
|
222 | (1) |
|
Peptostreptococcus and Related Genera |
|
|
222 | (1) |
|
|
222 | (4) |
|
|
226 | (1) |
|
Other Catalase-Negative Gram-Positive Cocci |
|
|
227 | (1) |
|
|
228 | (3) |
|
15 Enteric Gram-Negative Rods (Enterobacteriaceae) |
|
|
231 | (14) |
|
|
231 | (3) |
|
Diseases Caused By Enterobacteriaceae Other Than Salmonella and Shigella |
|
|
234 | (3) |
|
|
237 | (2) |
|
|
239 | (3) |
|
|
242 | (1) |
|
|
243 | (2) |
|
16 Pseudomonads and Acinetobacter |
|
|
245 | (8) |
|
|
245 | (1) |
|
|
245 | (3) |
|
Burkholderia pseudomallei |
|
|
248 | (1) |
|
Burkholderia cepacia Complex |
|
|
248 | (1) |
|
Stenotrophomonas maltophilia |
|
|
249 | (1) |
|
|
249 | (1) |
|
|
249 | (1) |
|
|
249 | (4) |
|
17 Vibrio, Campylobacter, and Helicobacter |
|
|
253 | (10) |
|
|
253 | (1) |
|
|
253 | (3) |
|
Vibrio parahaemolyticus and Vibrio vulnificus |
|
|
256 | (1) |
|
|
256 | (1) |
|
|
256 | (2) |
|
|
258 | (1) |
|
|
259 | (4) |
|
18 Haemophilus, Bordetella, Brucella, and Francisella |
|
|
263 | (12) |
|
|
263 | (1) |
|
|
263 | (2) |
|
|
265 | (1) |
|
Aggregatibacter aphrophilus |
|
|
266 | (1) |
|
|
266 | (1) |
|
Other Haemophilus Species |
|
|
266 | (1) |
|
|
266 | (1) |
|
|
266 | (2) |
|
|
268 | (1) |
|
Bordetella bronchiseptica |
|
|
268 | (1) |
|
|
269 | (2) |
|
Francisella tularensis and Tularemia |
|
|
271 | (2) |
|
|
273 | (2) |
|
19 Yersinia and Pasteurella |
|
|
275 | (6) |
|
Yersinia pestis and Plague |
|
|
275 | (2) |
|
|
277 | (1) |
|
|
278 | (1) |
|
|
278 | (3) |
|
|
281 | (12) |
|
|
281 | (6) |
|
|
287 | (1) |
|
|
288 | (1) |
|
|
289 | (1) |
|
|
289 | (4) |
|
21 Infections Caused by Anaerobic Bacteria |
|
|
293 | (8) |
|
Physiology and Growth Conditions for Anaerobes |
|
|
293 | (1) |
|
Anaerobic Bacteria Found in Human Infections |
|
|
294 | (1) |
|
Bacteria That Cause Vaginosis |
|
|
295 | (1) |
|
|
295 | (1) |
|
Pathogenesis of Anaerobic Infections |
|
|
296 | (1) |
|
The Polymicrobial Nature of Anaerobic Infections |
|
|
297 | (1) |
|
Diagnosis of Anaerobic Infections |
|
|
297 | (1) |
|
Treatment of Anaerobic Infections |
|
|
298 | (1) |
|
|
298 | (1) |
|
|
298 | (3) |
|
22 Legionella, Bartonella, and Unusual Bacterial Pathogens |
|
|
301 | (8) |
|
Legionella pneumophila and Other Legionellae |
|
|
301 | (3) |
|
|
304 | (2) |
|
Streptobacillus moniliformis |
|
|
306 | (1) |
|
|
306 | (1) |
|
|
307 | (2) |
|
|
309 | (14) |
|
Mycobacterium tuberculosis |
|
|
309 | (8) |
|
|
317 | (2) |
|
|
319 | (1) |
|
|
320 | (3) |
|
24 Spirochetes and Other Spiral Microorganisms |
|
|
323 | (12) |
|
Treponema pallidum and Syphilis |
|
|
323 | (4) |
|
|
327 | (1) |
|
Borrelia Species and Relapsing Fever |
|
|
327 | (1) |
|
Borrelia burgdorferi and Lyme Disease |
|
|
328 | (2) |
|
Leptospira and Leptospirosis |
|
|
330 | (2) |
|
|
332 | (3) |
|
25 Mycoplasmas and Cell Wall-Defective Bacteria |
|
|
335 | (6) |
|
|
335 | (2) |
|
Mycoplasma pneumoniae and Atypical Pneumonias |
|
|
337 | (1) |
|
|
338 | (1) |
|
|
338 | (1) |
|
|
338 | (1) |
|
|
338 | (1) |
|
|
339 | (2) |
|
26 Rickettsia and Related Genera |
|
|
341 | (10) |
|
|
341 | (1) |
|
|
341 | (4) |
|
|
345 | (1) |
|
|
346 | (2) |
|
|
348 | (3) |
|
|
351 | (12) |
|
Chlamydia trachomatis Ocular, Genital, and Respiratory Infections |
|
|
354 | (1) |
|
|
354 | (1) |
|
Chlamydia trachomatis Genital Infections and Inclusion Conjunctivitis |
|
|
355 | (1) |
|
Chlamydia trachomatis and Neonatal Pneumonia |
|
|
356 | (1) |
|
|
356 | (1) |
|
Chlamydia pneumoniae and Respiratory Infections |
|
|
357 | (1) |
|
Chlamydia psittaci and Psittacosis |
|
|
358 | (2) |
|
|
360 | (1) |
|
|
360 | (3) |
|
28 Antimicrobial Chemotherapy |
|
|
363 | (34) |
|
Mechanisms of Action of Antimicrobial Drugs |
|
|
363 | (1) |
|
|
363 | (1) |
|
Inhibition of Cell Wall Synthesis |
|
|
363 | (2) |
|
Inhibition/Alteration of Cell Membrane Function |
|
|
365 | (1) |
|
Inhibition of Protein Synthesis |
|
|
366 | (1) |
|
Inhibition of Nucleic Acid Synthesis |
|
|
367 | (1) |
|
Resistance to Antimicrobial Drugs |
|
|
368 | (1) |
|
Origin of Drug Resistance |
|
|
368 | (1) |
|
|
369 | (1) |
|
Limitation of Drug Resistance |
|
|
369 | (1) |
|
Clinical Implications of Drug Resistance |
|
|
369 | (1) |
|
Antimicrobial Activity in Vitro |
|
|
370 | (1) |
|
Factors Affecting Antimicrobial Activity |
|
|
370 | (1) |
|
Measurement of Antimicrobial Activity |
|
|
371 | (1) |
|
Antimicrobial Activity in Vivo |
|
|
372 | (1) |
|
Drug-Pathogen Relationships |
|
|
372 | (1) |
|
Host-Pathogen Relationships |
|
|
373 | (1) |
|
Clinical Use of Antibiotics |
|
|
373 | (1) |
|
|
373 | (1) |
|
Dangers of Indiscriminate Use |
|
|
374 | (1) |
|
Antimicrobial Drugs Used in Combination |
|
|
374 | (1) |
|
Antimicrobial Chemoprophylaxis |
|
|
375 | (2) |
|
Antimicrobial Drugs for Systemic Administration |
|
|
377 | (1) |
|
|
377 | (6) |
|
|
383 | (2) |
|
|
385 | (1) |
|
|
385 | (1) |
|
|
386 | (1) |
|
|
386 | (1) |
|
|
387 | (1) |
|
Clindamycin and Lincomycin |
|
|
387 | (1) |
|
Glycopeptides, Lipopeptides, Lipoglycopeptides |
|
|
388 | (1) |
|
|
388 | (1) |
|
|
389 | (1) |
|
|
389 | (1) |
|
|
389 | (1) |
|
|
389 | (2) |
|
|
391 | (1) |
|
Sulfonamides and Trimethoprim |
|
|
392 | (1) |
|
Other Drugs with Specialized Uses |
|
|
392 | (1) |
|
Drugs Used Primarily To Treat Mycobacterial Infections |
|
|
393 | (1) |
|
|
394 | (3) |
Section IV Virology |
|
397 | (260) |
|
|
29 General Properties of Viruses |
|
|
397 | (24) |
|
Terms and Definitions in Virology |
|
|
397 | (1) |
|
Evolutionary Origin of Viruses |
|
|
398 | (1) |
|
Classification of Viruses |
|
|
398 | (6) |
|
Principles of Virus Structure |
|
|
404 | (1) |
|
Chemical Composition of Viruses |
|
|
405 | (2) |
|
Cultivation and Detection of Viruses |
|
|
407 | (1) |
|
Purification and Identification of Viruses |
|
|
408 | (1) |
|
|
409 | (1) |
|
Reaction to Physical and Chemical Agents |
|
|
409 | (1) |
|
Replication of Viruses: an Overview |
|
|
410 | (4) |
|
Genetics of Animal Viruses |
|
|
414 | (2) |
|
Natural History (Ecology) and Modes of Transmission of Viruses |
|
|
416 | (2) |
|
|
418 | (1) |
|
|
418 | (3) |
|
30 Pathogenesis and Control of Viral Diseases |
|
|
421 | (20) |
|
Principles of Viral Diseases |
|
|
421 | (1) |
|
Pathogenesis of Viral Diseases |
|
|
421 | (12) |
|
Prevention and Treatment of Viral Infections |
|
|
433 | (5) |
|
|
438 | (1) |
|
|
438 | (3) |
|
|
441 | (6) |
|
Properties of Parvoviruses |
|
|
441 | (1) |
|
Parvovirus Infections in Humans |
|
|
441 | (4) |
|
|
445 | (1) |
|
|
445 | (2) |
|
|
447 | (10) |
|
Properties of Adenoviruses |
|
|
447 | (4) |
|
Adenovirus Infections in Humans |
|
|
451 | (3) |
|
|
454 | (1) |
|
|
454 | (3) |
|
|
457 | (26) |
|
Properties of Herpesviruses |
|
|
457 | (3) |
|
Herpesvirus Infections in Humans |
|
|
460 | (1) |
|
|
460 | (6) |
|
|
466 | (4) |
|
|
470 | (4) |
|
|
474 | (3) |
|
|
477 | (1) |
|
|
478 | (1) |
|
|
478 | (1) |
|
|
478 | (1) |
|
|
479 | (1) |
|
|
479 | (4) |
|
|
483 | (12) |
|
|
483 | (3) |
|
Poxvirus Infections in Humans: Vaccinia and Variola |
|
|
486 | (4) |
|
|
490 | (1) |
|
|
490 | (1) |
|
|
490 | (1) |
|
|
490 | (1) |
|
|
490 | (2) |
|
Tanapox and Yaba Monkey Tumor Poxvirus Infections |
|
|
492 | (1) |
|
|
493 | (1) |
|
|
493 | (2) |
|
|
495 | (20) |
|
Properties of Hepatitis Viruses |
|
|
495 | (5) |
|
Hepatitis Virus Infections in Humans |
|
|
500 | (12) |
|
|
512 | (1) |
|
|
512 | (3) |
|
36 Picornaviruses (Enterovirus and Rhinovirus Groups) |
|
|
515 | (16) |
|
Properties of Picornaviruses |
|
|
515 | (1) |
|
|
516 | (1) |
|
|
516 | (6) |
|
|
522 | (2) |
|
|
524 | (1) |
|
Enteroviruses in the Environment |
|
|
525 | (1) |
|
|
526 | (1) |
|
|
527 | (1) |
|
Foot-and-Mouth Disease (Aphthovirus of Cattle) |
|
|
528 | (1) |
|
|
528 | (1) |
|
|
528 | (3) |
|
37 Reoviruses, Rotaviruses, and Caliciviruses |
|
|
531 | (10) |
|
Reoviruses and Rotaviruses |
|
|
531 | (1) |
|
|
532 | (4) |
|
|
536 | (1) |
|
Orbiviruses and Coltiviruses |
|
|
536 | (1) |
|
|
536 | (3) |
|
|
539 | (1) |
|
|
539 | (1) |
|
|
539 | (2) |
|
38 Arthropod-Borne and Rodent-Borne Viral Diseases |
|
|
541 | (24) |
|
Human Arbovirus Infections |
|
|
541 | (2) |
|
Togavirus and Flavivirus Encephalitis |
|
|
543 | (7) |
|
|
550 | (2) |
|
|
552 | (2) |
|
Bunyavirus Encephalitis Viruses |
|
|
554 | (1) |
|
|
554 | (1) |
|
|
554 | (1) |
|
Severe Fever with Thrombocytopenia Syndrome Virus |
|
|
555 | (1) |
|
|
555 | (1) |
|
Colorado Tick Fever Virus |
|
|
555 | (1) |
|
Rodent-Borne Hemorrhagic Fevers |
|
|
555 | (1) |
|
|
555 | (2) |
|
|
557 | (2) |
|
|
559 | (2) |
|
|
561 | (1) |
|
|
561 | (4) |
|
39 Orthomyxoviruses (Influenza Viruses) |
|
|
565 | (14) |
|
Properties of Orthomyxoviruses |
|
|
565 | (5) |
|
Influenza Virus Infections in Humans |
|
|
570 | (6) |
|
|
576 | (1) |
|
|
576 | (3) |
|
40 Paramyxoviruses and Rubella Virus |
|
|
579 | (22) |
|
Properties of Paramyxoviruses |
|
|
579 | (4) |
|
Parainfluenza Virus Infections |
|
|
583 | (3) |
|
Respiratory Syncytial Virus Infections |
|
|
586 | (2) |
|
Human Metapneumovirus Infections |
|
|
588 | (1) |
|
|
589 | (2) |
|
Measles (Rubeola) Virus Infections |
|
|
591 | (3) |
|
Hendra Virus and Nipah Virus Infections |
|
|
594 | (1) |
|
Rubella (German Measles) Virus Infections |
|
|
595 | (1) |
|
|
595 | (1) |
|
Congenital Rubella Syndrome |
|
|
596 | (1) |
|
|
597 | (1) |
|
|
598 | (3) |
|
|
601 | (6) |
|
Properties of Coronaviruses |
|
|
601 | (1) |
|
Coronavirus Infections in Humans |
|
|
602 | (3) |
|
|
605 | (1) |
|
|
605 | (2) |
|
42 Rabies, Slow Virus Infections, and Prion Diseases |
|
|
607 | (12) |
|
|
607 | (6) |
|
|
613 | (1) |
|
Slow Virus Infections and Prion Diseases |
|
|
613 | (3) |
|
|
616 | (1) |
|
|
616 | (3) |
|
|
619 | (20) |
|
General Features of Viral Carcinogenesis |
|
|
619 | (1) |
|
Molecular Mechanisms of Carcinogensis |
|
|
620 | (1) |
|
Interactions of Tumor Viruses with Their Hosts |
|
|
621 | (1) |
|
|
622 | (1) |
|
|
622 | (1) |
|
|
622 | (6) |
|
|
628 | (1) |
|
|
628 | (2) |
|
|
630 | (3) |
|
|
633 | (1) |
|
|
633 | (1) |
|
|
634 | (1) |
|
|
634 | (1) |
|
How to Prove That a Virus Causes Human Cancer |
|
|
635 | (1) |
|
|
635 | (1) |
|
|
635 | (4) |
|
|
639 | (18) |
|
Properties of Lentiviruses |
|
|
639 | (4) |
|
|
643 | (10) |
|
|
653 | (1) |
|
|
653 | (4) |
Section V Mycology |
|
657 | (48) |
|
|
|
657 | (48) |
|
General Properties, Virulence, and Classification of Pathogenic Fungi |
|
|
658 | (5) |
|
Laboratory Diagnosis of Mycoses |
|
|
663 | (2) |
|
|
665 | (1) |
|
|
665 | (4) |
|
Key Concepts: Superficial and Cutaneous Mycoses |
|
|
669 | (1) |
|
|
669 | (1) |
|
|
670 | (1) |
|
|
671 | (1) |
|
|
672 | (1) |
|
|
673 | (1) |
|
Key Concepts: Subcutaneous Mycoses |
|
|
674 | (1) |
|
|
674 | (1) |
|
|
675 | (3) |
|
|
678 | (3) |
|
|
681 | (1) |
|
|
682 | (1) |
|
Key Concepts: Endemic Mycoses |
|
|
683 | (1) |
|
|
683 | (1) |
|
|
684 | (3) |
|
|
687 | (3) |
|
|
690 | (1) |
|
|
691 | (1) |
|
|
691 | (1) |
|
|
692 | (1) |
|
Other Opportunistic Mycoses |
|
|
693 | (1) |
|
Key Concepts: Opportunistic Mycoses |
|
|
693 | (1) |
|
|
693 | (1) |
|
Hypersensitivity to Fungi |
|
|
694 | (1) |
|
|
694 | (1) |
|
|
694 | (6) |
|
Topical Antifungal Agents |
|
|
700 | (1) |
|
Key Concepts: Antifungal Chemotherapy |
|
|
700 | (1) |
|
|
700 | (5) |
Section VI Parasitology |
|
705 | (36) |
|
|
|
|
705 | (36) |
|
Classification of Parasites |
|
|
705 | (4) |
|
Intestinal Protozoan Infections |
|
|
709 | (1) |
|
Giardia lamblia (Intestinal Flagellate) |
|
|
709 | (1) |
|
Entamoeba histolytica (Intestinal and Tissue Ameba) |
|
|
710 | (2) |
|
|
712 | (1) |
|
Cryptosporidium (Intestinal Sporozoa) |
|
|
712 | (1) |
|
Cyclospora (Intestinal Sporozoa) |
|
|
713 | (1) |
|
Sexually Transmitted Protozoan Infection |
|
|
713 | (1) |
|
Trichomonas vaginalis (Genitourinary Flagellate) |
|
|
713 | (1) |
|
Blood and Tissue Protozoan Infections |
|
|
713 | (1) |
|
|
713 | (1) |
|
Trypanosoma brucei rhodesiense and Trypanosoma brucei gambiense (Blood Flagellates) |
|
|
714 | (1) |
|
Trypanosoma cruzi (Blood Flagellate) |
|
|
715 | (1) |
|
Leishmania Species (Blood Flagellates) |
|
|
715 | (2) |
|
Entamoeba histolytica (Tissue Ameba)See Intestinal Protozoan Infections Section |
|
|
717 | (1) |
|
Naegleria fowleri, Acanthamoeba castellanii, and Balamuthia mandrillaris (Free-Living Amebae) |
|
|
717 | (1) |
|
Plasmodium Species (Blood Sporozoa) |
|
|
717 | (4) |
|
Babesia microti (Blood Sporozoa) |
|
|
721 | (1) |
|
Toxoplasma gondii (Tissue Sporozoa) |
|
|
722 | (1) |
|
|
722 | (1) |
|
Intestinal Helminthic Infections |
|
|
723 | (1) |
|
Enterobius vermicularis (PinwormIntestinal Nematode) |
|
|
723 | (1) |
|
Trichuris trichiura (WhipwormIntestinal Nematode) |
|
|
724 | (1) |
|
Ascaris lumbricoides (Human RoundwormIntestinal Nematode) |
|
|
724 | (4) |
|
Ancylostoma duodenale and Necator americanus (Human HookwormsIntestinal Nematode) |
|
|
728 | (1) |
|
Strongyloides stercoralis (Human ThreadwormIntestinal and Tissue Nematode) |
|
|
729 | (1) |
|
Trichinella spiralis (Intestinal and Tissue Nematode) |
|
|
730 | (1) |
|
Fasciolopsis buski (Giant Intestinal FlukeIntestinal Trematode) |
|
|
730 | (1) |
|
Taenia saginata (Beef TapewormIntestinal Cestode) and Taenia solium (Pork TapewormIntestinal and Tissue Cestode) |
|
|
731 | (1) |
|
Diphyllobothrium Tatum (Broad Fish TapewormIntestinal Cestode) |
|
|
731 | (1) |
|
Hymenolepis nana (Dwarf TapewormIntestinal Cestode) |
|
|
732 | (1) |
|
Dipylidium caninum (Dog TapewormIntestinal Cestode) |
|
|
732 | (1) |
|
Blood and Tissue Helminthic Infections |
|
|
732 | (1) |
|
Wuchereria bancrofti, brugia malayi, and Brugia timori (Lymphatic FilariasisTissue Nematodes) |
|
|
732 | (1) |
|
Onchocerca volvulus (River BlindnessTissue Nematode) |
|
|
733 | (1) |
|
Dracunculus medinensis (Guinea WormTissue Nematode) |
|
|
734 | (1) |
|
Larva Migrans (Zoonotic Larval Nematode Infections) |
|
|
734 | (1) |
|
Clonorchis sinensis (Chinese Liver Fluke), Fasciola hepatica (Sheep Liver Fluke), and Paragonimus westermani (Lung Fluke)Tissue Trematodes |
|
|
734 | (1) |
|
Schistosoma mansoni, Schistosoma japonicum, and Schistosoma haematobium (Blood Flukes) |
|
|
735 | (1) |
|
Tissue Cestode Infections (Caused By the Larval Stages) |
|
|
736 | (1) |
|
Taenia soliumCysticercosis/Neurocysticercosis |
|
|
736 | (1) |
|
Echinococcus granulosus (Hydatid Cyst) |
|
|
736 | (1) |
|
|
737 | (4) |
Section VII Diagnostic Medical Microbiology And Clinical Correlation |
|
741 | (68) |
|
|
|
47 Principles of Diagnostic Medical Microbiology |
|
|
741 | (32) |
|
Communication Between Physician and Laboratory |
|
|
741 | (1) |
|
Diagnosis of Bacterial and Fungal Infections |
|
|
742 | (11) |
|
The Importance of Normal Bacteria 1 and Fungal Microbiota |
|
|
753 | (1) |
|
Laboratory Aids in the Selection of Antimicrobial Therapy |
|
|
754 | (1) |
|
Diagnosis of Infection By Anatomic Site |
|
|
755 | (6) |
|
|
761 | (1) |
|
Diagnosis of Chlamydial Infections |
|
|
761 | (1) |
|
Diagnosis of Viral Infections |
|
|
762 | (7) |
|
|
769 | (4) |
|
48 Cases and Clinical Correlations |
|
|
773 | (36) |
|
|
773 | (4) |
|
|
777 | (5) |
|
|
782 | (1) |
|
|
783 | (2) |
|
|
785 | (5) |
|
|
790 | (2) |
|
Sexually Transmitted Diseases |
|
|
792 | (3) |
|
Mycobacterium tuberculosis Infections |
|
|
795 | (3) |
|
Myocobacterium avium Complex |
|
|
798 | (1) |
|
Infections in Transplant Patients |
|
|
799 | (6) |
|
|
805 | (4) |
Index |
|
809 | |